- Home
- BMO vs MCK Comparison
BMO vs MCK Comparison
Compare BMO & MCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMO | MCK |
|---|---|---|
| Founded | 1817 | 1833 |
| Country | Canada | United States |
| Employees | 53000 | N/A |
| Industry | Commercial Banks | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 119.6B | 91.0B |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | BMO | MCK |
|---|---|---|
| Price | $173.20 | $763.38 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 14 |
| Target Price | $163.00 | ★ $952.92 |
| AVG Volume (30 Days) | 626.8K | ★ 921.8K |
| Earning Date | 05-27-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.25% | 0.40% |
| EPS Growth | N/A | ★ 49.22 |
| EPS | N/A | ★ 38.38 |
| Revenue | N/A | ★ $112,084,000,000.00 |
| Revenue This Year | $19.43 | $14.94 |
| Revenue Next Year | $4.27 | $8.21 |
| P/E Ratio | ★ $17.46 | $19.41 |
| Revenue Growth | N/A | ★ 3.11 |
| 52 Week Low | $109.31 | $637.00 |
| 52 Week High | $173.93 | $999.00 |
Technical Indicators
Market Signals| Indicator | BMO | MCK |
|---|---|---|
| Relative Strength Index (RSI) | 76.99 | 46.97 |
| Support Level | $122.60 | $727.64 |
| Resistance Level | N/A | $779.31 |
| Average True Range (ATR) | 2.98 | 17.32 |
| MACD | 0.32 | 0.59 |
| Stochastic Oscillator | 91.94 | 48.29 |
Price Performance
Historical ComparisonAbout BMO Bank Of Montreal
Bank of Montreal is a diversified financial services provider based in North America with over CAD 1.47 trillion in assets by the end of fiscal 2025. BMO operates four business segments: Canadian personal and commercial banking, US personal and commercial banking, wealth management, and capital markets. About 60% of BMO's earnings are generated in Canada and 40% in the US.
About MCK McKesson Corporation
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.